California · Nonprofit
IMMUNOTHERAPY FOUNDATION
IMMUNOTHERAPY FOUNDATION (California) receives grants from 14 organizations whose IRS filings report $367,032 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($126,750). 5 of them have funded it in more than one year, and 67% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2021
- $93k
- Funders on record
- 14
- Grants received
- $367k
- Net assets
- $305k
What Immunotherapy Foundation does
Mission
Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.
As stated on its FY2021 Form 990-EZ.
Program
Our cause is to fund the following programs and studies:A cutting-edge cancer mutanome focused personalized immunotherapy program.A novel immune therapy for head and neck squamous cell carcinoma (HNSCC) that lays the framework for developing drugs, antibodies, and vaccines against cancers.Identification of a novel immune biomarker in the RNA sequence that allows us to predict and assess a patients response to immunotherapy.A robust clinical trial portfolio of immunotherapies for patients with HPV-related cancers, stressing studies with novel therapies, translational research, and biomarker discovery.
The first program described on its most recent Form 990-EZ.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $1.1M to $310k (−71%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 3%. Grants only. Government contracts and fees sit inside program revenue.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base narrowed from 2 funders to 1 funder, grant income fell $15k → $122.
5 of 14 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 67% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of IMMUNOTHERAPY FOUNDATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
IMMUNOTHERAPY FOUNDATION leans on a few funders — its largest provides 35% of grant income and the top three 69%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
67% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund IMMUNOTHERAPY FOUNDATION.
Largest funder’s share by year: 2017 67% · 2018 40% · 2019 33% · 2020 53% · 2021 100% · 2022 99% · 2023 100% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
14% of IMMUNOTHERAPY FOUNDATION's funders are still giving 3 years after their first grant; 36% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
67% of IMMUNOTHERAPY FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $120k that is directly attributable, 68% of it comes from California funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $247k arriving through sponsors registered in 4 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like IMMUNOTHERAPY FOUNDATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Public support
66%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for IMMUNOTHERAPY FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds IMMUNOTHERAPY FOUNDATION?
- IMMUNOTHERAPY FOUNDATION (California) receives grants from 14 organizations whose IRS filings report $367,032 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($126,750). 5 of them have funded it in more than one year, and 67% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does IMMUNOTHERAPY FOUNDATION have?
- IRS filings report 14 organizations giving $367,032 in grants to IMMUNOTHERAPY FOUNDATION, 5 of which have funded it in more than one year.
- Who is the largest funder of IMMUNOTHERAPY FOUNDATION?
- NATIONAL PHILANTHROPIC TRUST is the largest funder on record, with $126,750 in grants. The full list of funders is on this page.
- How can an organization like IMMUNOTHERAPY FOUNDATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2021 (financials across 2017–2021), and the filings of 14 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing